Benchmark Financial Wealth Advisors LLC Purchases 80 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Benchmark Financial Wealth Advisors LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% in the first quarter, according to its most recent filing with the SEC. The fund owned 775 shares of the healthcare conglomerate’s stock after acquiring an additional 80 shares during the quarter. Benchmark Financial Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $383,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. True Wealth Design LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the last quarter. Finally, Red Tortoise LLC raised its stake in shares of UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 23 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 12th. TD Cowen reduced their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Trading Down 0.9 %

Shares of NYSE UNH traded down $4.21 during trading on Friday, hitting $485.68. 734,356 shares of the company were exchanged, compared to its average volume of 4,249,500. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a market capitalization of $447.02 billion, a PE ratio of 29.94, a P/E/G ratio of 1.44 and a beta of 0.60. The company has a fifty day moving average price of $498.61 and a 200-day moving average price of $500.96. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.26 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.